Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05701150 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

AIO-BNHO Comprehensive Clinico-genomics Database Network - AIO-BNHO CONNECT

Study acronym: CONNECT
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 17, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Re-verified, no change to tracked fieldsv6
  2. Collaborators: 2 to 3v5 See this version in full on ClinicalTrials.gov ↗
  3. Collaborators expanded, about 13 wordsv4 See this version in full on ClinicalTrials.gov ↗
  4. Trial status: Not Yet Recruiting to Recruiting Primary and study completion dates: Feb 2025 to Dec 2025 · Study sites: 2 to 3 · Start date changed from estimate of Feb 2023 to Dec 8, 2022v3 Show 3 more changesShow less
    • Primary and study completion dates: Feb 2025 to Dec 2025
    • Study sites: 2 to 3
    • Start date changed from estimate of Feb 2023 to Dec 8, 2022
  5. Primary and study completion dates: Dec 8, 2025 to Feb 2025 Start date: Jan 20, 2023 to Feb 2023v2 Show 1 more changeShow less
    • Start date: Jan 20, 2023 to Feb 2023
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
National, retro- and prospective, observational, multicenter clinical research platform to connect clinical and genomic data of patients with advanced (locally advanced, inoperable, or metastatic) solid tumors (excluding NSCLC, SCLC, and mesothelioma) with results from multi-gene next-generation sequencing (NGS) panels (\>30 genes)
Trial Details
NCT Number NCT05701150
Lead Sponsor AIO-Studien-gGmbH
Collaborators: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company, Merck Sharp & Dohme LLC, Janssen-Cilag G.m.b.H
Conditions Advanced Solid Tumor
Enrollment 3,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov